Skip to main content
Top
Published in: BMC Women's Health 1/2021

Open Access 01-12-2021 | Ultrasound | Case report

Late presentation of extrauterine adenomyomas after laparoscopic morcellation at hysterectomy: a case report

Authors: Mohammed Nagdi Zaki, Aafia Mohammed Farooq Gheewale, Nada Ibrahim, Ibrahim Abd Elrahman

Published in: BMC Women's Health | Issue 1/2021

Login to get access

Abstract

Background

An adenomyoma is a well circumscribed form of adenomyosis and can be located within the myometrium, in the endometrium as a polyp, or extrauterine with the last being the rarest presentation amongst the three. With the ongoing advancement in gynecological surgery, the use of electromechanical morcellators have made the removal of large and dense specimens possible with minimally invasive techniques. However, it has also caused an increase in complications which were previously rare. Whilst the tissue is being grinded within the abdominal cavity, residual tissue can spread and remain inside, allowing for implantation to occur and thereby giving rise to recurrence of uterine tissue as a new late postoperative complication.
Case presentation
A 45-year-old woman presented with worsening constipation and right iliac fossa pain. Her past surgical history consists of laparoscopic supra-cervical hysterectomy that was indicated due to uterine fibroids. Computerized tomography and magnetic resonance imaging were done, which showed an irregular lobulated heterogeneous mass seen in the presacral space to the right, located on the right lateral aspect of the recto-sigmoid, measuring 4.5 × 4.3 × 4.3 cm in size. A transvaginal ultrasound revealed a cyst in the left ovary. The patient had a treatment course over several months that included Dienogest (progestin) and Goserelin (GnRH analogue) with add-back therapy. In line with the declining response to medications, the patient was advised for a laparoscopic ovarian cystectomy. During the surgery, an additional lesion was found as a suspected fibroid and the left ovarian cyst was identified as pockets of peritoneal fluid which was sent for cytology. The surgical pathology report confirmed adenomyosis in both specimens, namely the right mass and the initially suspected fibroid.

Conclusion

In this case report, we showcase a rare occurrence of an extrauterine adenomyoma presenting two years post laparoscopic morcellation at hysterectomy. This poses questions regarding the benefits versus risks of power morcellation in laparoscopic hysterectomy.
Literature
1.
go back to reference Bulut AS, Sipahi TU. Abscessed uterine and extrauterine adenomyomas with uterus-like features in a 56-year-old woman. Case Rep Obstet Gynecol. 2013;2013:1–5. CrossRef Bulut AS, Sipahi TU. Abscessed uterine and extrauterine adenomyomas with uterus-like features in a 56-year-old woman. Case Rep Obstet Gynecol. 2013;2013:1–5. CrossRef
2.
go back to reference Devlieger R. Uterine adenomyosis in the infertility clinic. Hum Reprod Update. 2003;9(2):139–47.CrossRef Devlieger R. Uterine adenomyosis in the infertility clinic. Hum Reprod Update. 2003;9(2):139–47.CrossRef
3.
go back to reference Taran F, Stewart E, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd. 2013;73(09):924–31.CrossRef Taran F, Stewart E, Brucker S. Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd. 2013;73(09):924–31.CrossRef
4.
go back to reference Dessouky R, Gamil SA, Nada MG, Mousa R, Libda Y. Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy. Insights Imaging. 2019;10(1):1–9. CrossRef Dessouky R, Gamil SA, Nada MG, Mousa R, Libda Y. Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy. Insights Imaging. 2019;10(1):1–9. CrossRef
5.
go back to reference Yi C, Li L, Wang X, Liu X. Recurrence of uterine tissue residues after laparoscopic hysterectomy or myomectomy. Pak J Med Sci. 2014;30(5):1134–6.CrossRef Yi C, Li L, Wang X, Liu X. Recurrence of uterine tissue residues after laparoscopic hysterectomy or myomectomy. Pak J Med Sci. 2014;30(5):1134–6.CrossRef
7.
go back to reference Brolmann HA, Sizzi O, Hehenkamp WJ, Rossetti A. Laparoscopic power morcellation of presumed fibroids. Minerva Ginecol. 2016;68(3):352–63.PubMed Brolmann HA, Sizzi O, Hehenkamp WJ, Rossetti A. Laparoscopic power morcellation of presumed fibroids. Minerva Ginecol. 2016;68(3):352–63.PubMed
8.
go back to reference Parker W, Pritts E, Olive D. Morcellation for gynecologic surgery. Clin Obstet Gynecol. 2019;62(4):727–32.CrossRef Parker W, Pritts E, Olive D. Morcellation for gynecologic surgery. Clin Obstet Gynecol. 2019;62(4):727–32.CrossRef
9.
go back to reference Hall T, Lee SI, Boruta DM, Goodman A. Medical device safety and surgical dissemination of unrecognized uterine malignancy: morcellation in minimally invasive gynecologic surgery. Oncologist. 2015;20(11):1274–82.CrossRef Hall T, Lee SI, Boruta DM, Goodman A. Medical device safety and surgical dissemination of unrecognized uterine malignancy: morcellation in minimally invasive gynecologic surgery. Oncologist. 2015;20(11):1274–82.CrossRef
10.
go back to reference Brölmann H. European Society for Gynaecological Endoscopy: ESGE newsletter. Gynecol Surg. 2006;3(1):70–1.CrossRef Brölmann H. European Society for Gynaecological Endoscopy: ESGE newsletter. Gynecol Surg. 2006;3(1):70–1.CrossRef
11.
go back to reference Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, et al. Options on fibroid morcellation: a literature review. Gynecol Surg. 2015;12(1):3–15.CrossRef Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, et al. Options on fibroid morcellation: a literature review. Gynecol Surg. 2015;12(1):3–15.CrossRef
13.
go back to reference Miller CE. Morcellation equipment. Curr Opin Obstet Gynecol. 2018;30(1):69–74.CrossRef Miller CE. Morcellation equipment. Curr Opin Obstet Gynecol. 2018;30(1):69–74.CrossRef
14.
go back to reference Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis—prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Repord. 2005;20(8):2309–16.CrossRef Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis—prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Repord. 2005;20(8):2309–16.CrossRef
15.
go back to reference Paul PG, Gulati G, Shintre H, et al. Extrauterine adenomyoma: a review of the literature. Eur J Obstet Gynecol Reprod Biol. 2018;228:130–6.CrossRef Paul PG, Gulati G, Shintre H, et al. Extrauterine adenomyoma: a review of the literature. Eur J Obstet Gynecol Reprod Biol. 2018;228:130–6.CrossRef
16.
go back to reference Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.CrossRef Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.CrossRef
17.
go back to reference Hodge JC, Morton CC. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Hum Mol Genet. 2007;16:R7–13.CrossRef Hodge JC, Morton CC. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Hum Mol Genet. 2007;16:R7–13.CrossRef
18.
go back to reference Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol. 1994;83(3):414–8.PubMed Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol. 1994;83(3):414–8.PubMed
20.
go back to reference Katsumata Y, Noda M, Tanaka M, et al. CT appearance of uterine adenomyosis. Rinsho Hoshasen. 1989;34(2):227–32.PubMed Katsumata Y, Noda M, Tanaka M, et al. CT appearance of uterine adenomyosis. Rinsho Hoshasen. 1989;34(2):227–32.PubMed
21.
go back to reference Svajdler M, Svajdler P. Frozen section: history, indications, contraindications and quality assurance. Cesk Patol. 2018;54(2):58–62.PubMed Svajdler M, Svajdler P. Frozen section: history, indications, contraindications and quality assurance. Cesk Patol. 2018;54(2):58–62.PubMed
22.
go back to reference Adios J, Verissimo R, Almeida J, et al. Frozen section in the management of ovarian and uterine tumors: the past 5 years in a Tertiary Centre. Rev Bras Ginecol Obstet. 2018;40(08):458–64.CrossRef Adios J, Verissimo R, Almeida J, et al. Frozen section in the management of ovarian and uterine tumors: the past 5 years in a Tertiary Centre. Rev Bras Ginecol Obstet. 2018;40(08):458–64.CrossRef
23.
go back to reference Bergeron C, Amant F, Ferenczy A. Pathology and pathophysiology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):511–21.CrossRef Bergeron C, Amant F, Ferenczy A. Pathology and pathophysiology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):511–21.CrossRef
24.
go back to reference Ferrero S, Scala C, Vellone VG, Biscaldi E, Barra F. Transvaginal ultrasound-guided biopsy of adenomyosis. Ann Transl Med. 2019;7(S8):S341.CrossRef Ferrero S, Scala C, Vellone VG, Biscaldi E, Barra F. Transvaginal ultrasound-guided biopsy of adenomyosis. Ann Transl Med. 2019;7(S8):S341.CrossRef
25.
go back to reference Hirata T, Izumi G, Takamura M, Saito A, Nakazawa A, Harada M, et al. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study. Gynecol Endocrinol. 2014;30(10):726–9.CrossRef Hirata T, Izumi G, Takamura M, Saito A, Nakazawa A, Harada M, et al. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study. Gynecol Endocrinol. 2014;30(10):726–9.CrossRef
26.
go back to reference Chen M, Luo L, Wang Q, Gao J, Chen Y, Zhang Y, et al. Impact of Gonadotropin-releasing hormone agonist pre-treatment on the cumulative live birth rate in infertile women with adenomyosis treated with IVF/ICSI: a retrospective cohort study. Front Endocrinol (Lausanne). 2020;11:318.CrossRef Chen M, Luo L, Wang Q, Gao J, Chen Y, Zhang Y, et al. Impact of Gonadotropin-releasing hormone agonist pre-treatment on the cumulative live birth rate in infertile women with adenomyosis treated with IVF/ICSI: a retrospective cohort study. Front Endocrinol (Lausanne). 2020;11:318.CrossRef
27.
go back to reference Hackenberg R, Gesenhues T, Deichert U, Duda V, Schmidt-Rhode P, Schulz K-D. The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month. Eur J Obstet Gynecol Reprod Biol. 1992;45(2):125–9.CrossRef Hackenberg R, Gesenhues T, Deichert U, Duda V, Schmidt-Rhode P, Schulz K-D. The response of uterine fibroids to GnRH-agonist treatment can be predicted in most cases after one month. Eur J Obstet Gynecol Reprod Biol. 1992;45(2):125–9.CrossRef
28.
go back to reference Matsushima T, Akira S, Fukami T, Yoneyama K, Takeshita T. Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis. Gynecol Minim Invasive Ther. 2018;7(3):119–23.CrossRef Matsushima T, Akira S, Fukami T, Yoneyama K, Takeshita T. Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis. Gynecol Minim Invasive Ther. 2018;7(3):119–23.CrossRef
Metadata
Title
Late presentation of extrauterine adenomyomas after laparoscopic morcellation at hysterectomy: a case report
Authors
Mohammed Nagdi Zaki
Aafia Mohammed Farooq Gheewale
Nada Ibrahim
Ibrahim Abd Elrahman
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2021
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01408-z

Other articles of this Issue 1/2021

BMC Women's Health 1/2021 Go to the issue